menu
    • menu
    [{"orgOrder":0,"company":"Gencor","sponsor":"Gencor","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"U.S.A","productType":"Miscellaneous","year":"2022","type":"Inapplicable","leadProduct":"Palmitoylethanolamide","moa":"TNF-alpha receptor","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Phase II","graph3":"Gencor","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Gencor \/ Gencor","highestDevelopmentStatusID":"8","companyTruncated":"Gencor \/ Gencor"},{"orgOrder":0,"company":"Gencor","sponsor":"RDC Clinical","pharmaFlowCategory":"DU","therapeuticArea":"Sleep","country":"AUSTRALIA","productType":"Dietary Supplement","year":"2026","type":"Inapplicable","leadProduct":"Lavender Oil","moa":"Undisclosed","graph1":"Sleep","graph2":"Phase II","graph3":"Gencor","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Sleep","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Gencor \/ Gencor","highestDevelopmentStatusID":"8","companyTruncated":"Gencor \/ Gencor"}]

    Find Clinical Drug Pipeline Developments & Deals by Gencor

    Menu

    Gencor

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Gencor

                            U.S.A arrow
                            Biotech Showcase
                            Not Confirmed

                            Gencor

                            U.S.A arrow
                            Biotech Showcase
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lavender Oil,Palmitoylethanolamide,Oleoylethanolamide

                            Therapeutic Area : Sleep

                            Study Phase : Phase II

                            Recipient : RDC Clinical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Sleep and Stress Study

                            Details : Lavender Oil is a dietary supplement drug, which is currently being evaluated in Phase II clinical studies for the treatment of Sleep Wake Disorders.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            January 02, 2026

                            Lead Product(s) : Lavender Oil,Palmitoylethanolamide,Oleoylethanolamide

                            Therapeutic Area : Sleep

                            Highest Development Status : Phase II

                            Recipient : RDC Clinical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Gencor

                            U.S.A arrow
                            Biotech Showcase
                            Not Confirmed

                            Gencor

                            U.S.A arrow
                            Biotech Showcase
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Palmitoylethanolamide

                            Therapeutic Area : Orthopedics/Orthopedic Surgery

                            Study Phase : Phase II

                            Recipient : University of California, Irvine

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of Palmitoylethanolamide on Reducing Opioid Consumption for Below Knee Fracture Fixation

                            Details : Palmitoylethanolamide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Tibial Fractures.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            April 08, 2022

                            Lead Product(s) : Palmitoylethanolamide

                            Therapeutic Area : Orthopedics/Orthopedic Surgery

                            Highest Development Status : Phase II

                            Recipient : University of California, Irvine

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.